OTCMKTS:CVALF Covalon Technologies 5/29/2024 Earnings Report $1.49 -0.03 (-1.71%) As of 10/7/2025 03:18 PM Eastern ProfileEarnings History Covalon Technologies EPS ResultsActual EPS$0.04Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ACovalon Technologies Revenue ResultsActual Revenue$6.22 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ACovalon Technologies Announcement DetailsQuarterDate5/29/2024TimeN/AConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Covalon Technologies Earnings HeadlinesCovalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHONSeptember 25, 2025 | businesswire.comEvidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual MeetingSeptember 18, 2025 | businesswire.comStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.October 8 at 2:00 AM | Paradigm Press (Ad)Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial ResultsAugust 22, 2025 | theglobeandmail.comCovalon Technologies Ltd. (CVALF) Q3 2025 Earnings Call TranscriptAugust 21, 2025 | seekingalpha.comCORRECTING and REPLACING Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial ResultsAugust 14, 2025 | businesswire.comSee More Covalon Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Covalon Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Covalon Technologies and other key companies, straight to your email. Email Address About Covalon TechnologiesCovalon Technologies (OTCMKTS:CVALF) (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials. The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components. Its hydrogel dressings are designed to maintain a moist healing environment, manage exudate, and provide sustained antimicrobial protection. Covalon’s coating technology is applied to catheters, implantable devices and wound-care products to inhibit bacterial adhesion and biofilm formation, addressing a critical need in hospital and outpatient surgical settings. Covalon has secured regulatory approvals in Canada and holds CE marking for distribution across Europe. The company is actively pursuing regulatory clearance in the United States and has established distribution partnerships in Asia and the Middle East. Its products are supplied to hospitals, surgical centers and wound-care clinics, where infection prevention and efficient healing are paramount to patient outcomes. Founded in the late 1980s, Covalon pivoted to focus on medical polymer applications in the early 2000s and has since built a pipeline of antimicrobial and anti-adhesion technologies. The company’s leadership team brings together expertise in polymer chemistry, medical device development and clinical research to advance its platform. Covalon continues to invest in research and development to expand its product offerings and geographic reach, supporting healthcare professionals in the global fight against device-associated infections and chronic wounds.View Covalon Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings Upcoming Earnings PepsiCo (10/9/2025)Fastenal (10/13/2025)BlackRock (10/14/2025)Citigroup (10/14/2025)The Goldman Sachs Group (10/14/2025)Johnson & Johnson (10/14/2025)JPMorgan Chase & Co. (10/14/2025)Wells Fargo & Company (10/14/2025)ASML (10/15/2025)Abbott Laboratories (10/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
